financetom
Business
financetom
/
Business
/
Kaiser Aluminum Q3 profit beats, raises annual EBITDA outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kaiser Aluminum Q3 profit beats, raises annual EBITDA outlook
Oct 22, 2025 2:25 PM

Overview

* Kaiser Aluminum ( KALU ) Q3 net sales missed analyst expectations

* Adjusted net income for Q3 beats analyst expectations

* Company raises full-year 2025 adjusted EBITDA outlook

Outlook

* Kaiser Aluminum ( KALU ) raises full-year 2025 Adjusted EBITDA outlook by 20% to 25%

* Company expects 2025 Conversion Revenue to be flat to up 5% year-over-year

Result Drivers

* METAL PRICE TAILWINDS - Favorable metal prices offset $20 mln non-recurring startup costs at Trentwood and Warrick facilities

* SHIPMENT DECREASE - Shipments fell 8% due to planned partial outage at Trentwood facility

* INCREASED SALES PRICE - Average realized sales price rose due to 28% increase in Hedged Cost of Alloyed Metal

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Miss $844 mln $850 mln

(2

Analysts

)

Q3 EPS $2.38

Q3 Beat $31 mln $15 mln

Adjusted (2

Net Analysts

Income )

Q3 Net $40 mln

Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the aluminum peer group is "buy"

* Wall Street's median 12-month price target for Kaiser Aluminum Corp ( KALU ) is $90.00, about 11.4% above its October 21 closing price of $79.75

* The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lightwave Logic Extends CEO's Tenure Until 2028; Announces CFO, COO Retirement
Lightwave Logic Extends CEO's Tenure Until 2028; Announces CFO, COO Retirement
Sep 16, 2025
05:23 PM EDT, 09/16/2025 (MT Newswires) -- Lightwave Logic ( LWLG ) said late Tuesday its board and Chief Executive Yves LeMaitre have agreed to extend his employment term until the end of 2028. The electro-optic polymer materials company's Chief Financial Officer and Chief Operating Officer Jim Marcelli will also be retiring at the end of 2025. Lightwave said it...
Kura Oncology Hosts Event Focused on Farnesyl Transferase Inhibitor Program
Kura Oncology Hosts Event Focused on Farnesyl Transferase Inhibitor Program
Sep 16, 2025
05:27 PM EDT, 09/16/2025 (MT Newswires) -- Kura Oncology ( KURA ) said Tuesday it is hosting the first of two events for analysts and investors focused on its farnesyl transferase inhibitor, or FTI, program. The event will feature preclinical data showing the potential of FTIs to improve the anti-tumor activity of targeted treatments in diverse tumor types, the company...
Globus Medical Insider Sold Shares Worth $584,600, According to a Recent SEC Filing
Globus Medical Insider Sold Shares Worth $584,600, According to a Recent SEC Filing
Sep 16, 2025
05:22 PM EDT, 09/16/2025 (MT Newswires) -- Ann D Rhoads, Director, on September 15, 2025, sold 10,000 shares in Globus Medical ( GMED ) for $584,600. Following the Form 4 filing with the SEC, Rhoads has control over a total of 25,384 Class A common shares of the company, with 25,384 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1237831/000119312525205135/xslF345X05/ownership.xml ...
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing
Sep 16, 2025
05:22 PM EDT, 09/16/2025 (MT Newswires) -- Johanna Mercier, Chief Commercial Officer, on September 15, 2025, sold 3,000 shares in Gilead Sciences ( GILD ) for $340,710. Following the Form 4 filing with the SEC, Mercier has control over a total of 113,193 common shares of the company, with 113,193 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/882095/000178213525000008/xslF345X05/wk-form4_1758057358.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved